Trevi Therapeutics, Inc. (TRVI) › Weighted Average Diluted SharesTrevi Therapeutics, Inc. (TRVI) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2021-12-31: 22.84M2022-12-31: 64.54M2023-12-31: 99.03M2024-12-31: 101.97M2025-12-31: 134.75M134.75M2021-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31134.75M+32.1%2026-03-17From 2025-01-012024-12-31101.97M+3.0%2026-03-17From 2024-01-012023-12-3199.03M+53.4%2025-03-18From 2023-01-012022-12-3164.54M+182.6%2024-03-20From 2022-01-012021-12-3122.84M—2023-03-16From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)